Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity
- 21 October 2008
- Vol. 382 (2) , 226-238
- https://doi.org/10.1016/j.virol.2008.09.019
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcriptionProceedings of the National Academy of Sciences, 2007
- The Nucleocytoplasmic Rabies Virus P Protein Counteracts Interferon Signaling by Inhibiting both Nuclear Accumulation and DNA Binding of STAT1Journal of Virology, 2007
- Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus VectorJournal of Virology, 2006
- A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodiesJournal of General Virology, 2005
- Covalently Linked Human Immunodeficiency Virus Type 1 gp120/gp41 Is Stably Anchored in Rhabdovirus Particles and Exposes Critical Neutralizing EpitopesJournal of Virology, 2003
- Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector GenomeJournal of Virology, 2003
- Rabies virus matrix protein regulates the balance of virus transcription and replicationJournal of General Virology, 2003
- Type I Interferon Induction Pathway, but Not Released Interferon, Participates in the Maturation of Dendritic Cells Induced by Negative?Strand RNA VirusesThe Journal of Infectious Diseases, 2003
- Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly ImmunogenicJournal of Virology, 2003
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994